文献速递头颈外科

《平价医疗法案》对喉癌结局的影响:一项NCDB研究

The Impact of the Affordable Care Act on Laryngeal Carcinoma Outcomes: A NCDB Study.
PubMed 文献 · Otolaryngol Head Neck Surg · 2025-06-19

该横断面研究基于美国国家癌症数据库2004—2018年确诊的喉癌患者(n=28,843),评估《平价医疗法案》(ACA)及医疗补助扩展对疾病分期和总生存的影响。结果显示ACA后喉癌年患病率在扩展州和非扩展州均显著上升,IV期比例也显著增加;非扩展州ACA后生存无显著差异(HR 0.990,95%CI 0.933-1.052),扩展州ACA后生存改善(HR 0.904,95%CI 0.857-0.954)。

要点

  • ACA后喉癌年患病率在非扩展州和扩展州均显著上升(均P < .001)。
  • ACA后IV期喉癌比例在非扩展州(45.1% vs 33.1%)和扩展州(41.8% vs 32.5%)均显著增加(均P < .001)。
  • 非扩展州ACA后生存无显著差异(HR 0.990,95%CI 0.933-1.052),扩展州生存改善(HR 0.904,95%CI 0.857-0.954)。

核心结论

  • ACA扩大医疗可及性使喉癌诊断增加,晚期疾病诊断也增加;ACA后生存差异仅在医疗补助扩展州显著。

研究设计与样本

  • 横断面研究,基于美国国家癌症数据库2004—2018年确诊的喉癌患者(n=28,843),采用Cox比例风险回归分析总生存。

主要发现

  • 喉癌年患病率ACA后(2010—2018)较ACA前(2004—2010)在非扩展州和扩展州均显著增加(均P < .001)。
  • IV期疾病ACA后较ACA前在非扩展州(45.1% vs 33.1%,P < .001)和扩展州(41.8% vs 32.5%,P < .001)均显著增加。
  • 非扩展州ACA后确诊患者生存与ACA前无显著差异(HR 0.990,95%CI 0.933-1.052)。
  • 扩展州ACA后确诊患者生存较ACA前改善(HR 0.904,95%CI 0.857-0.954)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Affordable Care Act (ACA) of 2010 aimed to improve access to care in the United States by expanding the population eligible for Medicaid coverage and has been associated with decreased rates of uninsurance and increased likelihood of early head and neck cancer diagnosis. This study aims to assess the impact of the ACA and expansion of Medicaid on disease presentation and overall survival for patients with laryngeal carcinoma. STUDY DESIGN: Cross-sectional study. SETTING: Multicenter clinical database. METHODS: Overall survival was assessed with Cox proportional hazard regression analyses for patients diagnosed with laryngeal carcinoma (n = 28,843) between 2004 and 2018 in the National Cancer Database. RESULTS: The annual prevalence of laryngeal carcinoma significantly increased post-ACA (2010-2018) compared to pre-ACA (2004-2010) for both non-expansion (P < .001) and expansion states (P < .001). There was a statistically significant increase in stage IV disease post-ACA for both non-expansion states (45.1% post vs 33.1% pre, P < .001) and expansion states (41.8% post vs 32.5% pre, P < .001). There was no significant difference in survival for patients diagnosed with laryngeal cancer post-ACA (hazard ratio [HR] 0.990, 95% CI 0.933-1.052) compared to pre-ACA in non-expansion states. Expansion states had improved survival post-ACA (HR 0.904, 95% CI 0.857-0.954) compared to pre-ACA. CONCLUSION: Increased access to care with the ACA led to increased diagnosis of laryngeal carcinoma and increased diagnosis of late-stage disease. Although there were significant differences in survival between expansion and non-expansion states, significant differences in survival outcomes post-ACA were only noted in expansion states.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Nurimba MC, Thompson ZE, Chambers TN, et al. The Impact of the Affordable Care Act on Laryngeal Carcinoma Outcomes: A NCDB Study. Otolaryngol Head Neck Surg. 2025. PMID: 40536178. doi:10.1002/ohn.1336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。